Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia

Схожие документы

• Identification of volasertib-resistant mechanism and evaluation of combination effects with volasertib and other agents on acute myeloid leukemia
  по: Adachi, Yoshiya, и др.
  Опубликовано: (2017)
• Strategic and Statistical Considerations on the QT Assessment of Volasertib
  по: Wallenstein, Gudrun, и др.
  Опубликовано: (2017)
• Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
  по: Gjertsen, B T, и др.
  Опубликовано: (2015)
• Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
  по: Bjørn Tore Gjertsen, и др.
  Опубликовано: (2014)
• A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
  по: C-C. Lin, и др.
  Опубликовано: (2014)